70
Informaciones
Psiquiátricas
2015 - n.º 220
Anna Prats
Bibliografía
1. Andlin-Sobocki P, Jönsson B, Wittchen
HU, Olesen J. Cost of disorders of the
brain in Europe. Eur J Neurol. 2005
Jun;12 Suppl 1:1-27.
2. Chaudhuri KR, Odin P, Antonini A, Mar-
tinez-Martin P. Parkinson’s disease: The
non-motor issues. Parkinsonism Relat
Disord. 2011;17:717–723.
3. Jankovic J. Parkinson’s disease: clinical
features and diagnosis. J Neurol Neuro-
surg Psychiatry. 2008 Apr;79(4):368-76.
4. Elgh E, Domellöf M, Linder J, Edström
M, Stenlund H, Forsgren L. Cognitive
function in early Parkinson’s disease: a
population-based study. Eur J Neurol.
2009 Dec;16(12):1278-84.
5. Yarnall AJ, Breen DP, Duncan GW, Khoo
TK, Coleman SY, Firbank MJ, et al.;
ICICLE-PD Study Group. Characterizing
mild cognitive impairment in incident
Parkinson disease: the ICICLE-PD study.
Neurology. 2014 Jan 28;82(4):308-16.
6. Marras C, Rochon P, Lang AE. Predicting
motor decline and disability in Parkin-
son disease: a systematic review. Arch
Neurol. 2002 Nov;59(11):1724-8. Re-
view.
7. Rosenthal E, Brennan L, Xie S, Hurtig H,
Milber J, Weintraub D, et al. Association
between cognition and function in pa-
tients with Parkinson disease with and
without dementia. Mov Disord. 2010 Jul
15;25(9):1170-6.
8. Reginold W, Duff-Canning S, Meaney C,
Armstrong MJ, Fox S, Rothberg B, et
al. Impact of mild cognitive impair-
ment on health-related quality of life
in Parkinson’s disease. Dement Geriatr
Cogn Disord. 2013;36(1-2):67-75.
9. Leroi I, McDonald K, Pantula H, Har-
bishettar V. Cognitive impairment in
Parkinson disease: impact on quality
of life, disability, and caregiver bur-
den. J Geriatr Psychiatry Neurol. 2012
Dec;25(4):208-14.
10. Buter TC, van den Hout A, Matthews FE,
Larsen JP, Brayne C, Aarsland D. Demen-
tia and survival in Parkinson disease: a
12-year population study. Neurology.
2008 Mar 25;70(13):1017-22.
11. Aarsland D, Larsen JP, Tandberg E, La-
ake K. Predictors of nursing home pla-
cement in Parkinson’s disease: a popu-
lation-based, prospective study. J Am
Geriatr Soc. 2000 Aug;48(8):938-42.
12. McKeith I. Dementia in Parkinson’s di-
sease: common and treatable. Lancet
Neurol. 2004 Aug;3(8):456.
13. Aarsland D, Andersen K, Larsen JP, Lolk
A, Kragh-Sørensen P. Prevalence and
characteristics of dementia in Parkinson
disease: an 8-year prospective study.
Arch Neurol. 2003 Mar;60(3):387-92.
14. Emre M, Aarsland D, Albanese A, Byrne
EJ, Deuschl G, De Deyn PP, et al. Rivas-
tigmine for dementia associated with
Parkinson’s disease. N Engl J Med. 2004
Dec 9;351(24):2509-18.
